How do you manage anemia in a patient with myelofibrosis and hemochromatosis?
Patient on JAK2i, ESA, transfusion dependent
2 Answers
Mednet MemberInvited Expert
Hematology · Georgetown University School of Medicine
Answered on
It is a good question. There isn’t much more you can do. There are new targeted therapies for myelofibrosis which are best answered by an MPD specialist. As for the hemochromatosis, you should still check iron parameters, because if deficiency is present it SHOULD be treated, in this case with IV ir...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Taussig Cancer Institute
Answered on
I agree, a very difficult problem. You can still work down the typical pathway for treating anemia in myelofibrosis, by using epo levels to determine if an ESA can be used. If the epo level is high then consider alternatives like luspatercept (based on a phase 2 study in MF) or danazol.
There is dat...
Join for free or sign in to see the full answer